Wells Fargo & Company Teva Pharmaceutical Industries LTD Call Options Transaction History

Wells Fargo & Company

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 13, 2024	BUY	$15.81 - $18.96 $2.77 Million - $3.32 Million	175,000 New	175,000 $3.15 Million
Q2 2022 Aug 12, 2022	BUY	$7.38 - $10.4 $1.53 Million - $2.15 Million	206,800 Added 478.7%	250,000 $1.88 Million
Q1 2021 May 13, 2021	SELL	$10.34 - $12.81 $2.14 Million - $2.65 Million	-206,800 Reduced 82.72%	43,200 $499,000
Q4 2020 Feb 09, 2021	SELL	$8.61 - $11.04 $1.72 Million - $2.21 Million	-200,000 Reduced 44.44%	250,000 $59,000
Q1 2020 May 14, 2020	BUY	$6.69 - $13.45 $3.01 Million - $6.05 Million	450,000 New	450,000 $210,000

624

573M

19.6M

6.77M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $18.9B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.